Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 38 Neoplasm Metastasis 14 Liver Neoplasms 11 Colorectal Neoplasms 11 Cholangiocarcinoma 9 Pancreatic Neoplasms 8 Lung Neoplasms 8 Colonic Neoplasms 7 Breast Neoplasms 7 Thyroid Nodule 6 Recurrence 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Thyroid Neoplasms 5 Rectal Neoplasms 4 Neoplasms 4 Esophageal Neoplasms 4 Prostatic Neoplasms 3 Pain 3 Kidney Neoplasms 3 Barrett Esophagus 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Leiomyoma 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2 Bile Duct Neoplasms 2 Adrenocortical Adenoma 2

Interventions

Osilodrostat 2 Metyrapone 2 pasireotide 1 Staining and Labeling 1 Radiofrequency Ablation 1 Kangaroo-Mother Care Method 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × ACTH Syndrome, Ectopic × Radiofrequency Ablation × Clear all

NCT02756754 2026-05-04

ADERADHTA

University Hospital, Toulouse

Phase NA Completed

ACTH Syndrome, Ectopic, Hyperaldosteronism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡